130 related articles for article (PubMed ID: 6549258)
1. Phospholipids in tracheal effluent from infants with severe respiratory distress syndrome.
Bose CL; Richardson P; Wood B; Gonzalez F; King J
Am J Perinatol; 1984 Apr; 1(3):208-13. PubMed ID: 6549258
[TBL] [Abstract][Full Text] [Related]
2. [Tracheal phospholipid composition and respiratory distress syndrome of the newborn].
Obladen M
Fortschr Med; 1979 Mar; 97(9):403-8. PubMed ID: 581867
[TBL] [Abstract][Full Text] [Related]
3. Absence of phosphatidylglycerol (PG) in respiratory distress syndrome in the newborn. Study of the minor surfactant phospholipids in newborns.
Hallman M; Feldman BH; Kirkpatrick E; Gluck L
Pediatr Res; 1977 Jun; 11(6):714-20. PubMed ID: 577302
[TBL] [Abstract][Full Text] [Related]
4. Improving the prediction of surfactant deficiency in very low-birthweight infants with respiratory distress.
Harker LC; Merritt TA; Edwards DK
J Perinatol; 1992 Jun; 12(2):129-33. PubMed ID: 1522430
[TBL] [Abstract][Full Text] [Related]
5. RDS and tracheal phospholipid composition in twins: independent of gestational age.
Obladen M; Gluck L
J Pediatr; 1977 May; 90(5):799-802. PubMed ID: 576875
[TBL] [Abstract][Full Text] [Related]
6. [The lung phospholipid content in newborn infants with idiopathic respiratory distress syndrome in relation to lung histology and survival time (author's transl)].
Krepler R; Davidovits A; Eckerstorfer R; Denk H
Wien Klin Wochenschr; 1976 Sep; 88(17):554-7. PubMed ID: 1036640
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous measurement of phosphatidylglycerol and disaturated-phosphatidylcholine palmitate kinetics from alveolar surfactant. Study in infants with stable isotope tracer, coupled with isotope ratio mass spectrometry.
Vedovelli L; Baritussio A; Carnielli VP; Simonato M; Giusti P; Cogo PE
J Mass Spectrom; 2011 Oct; 46(10):986-92. PubMed ID: 22012664
[TBL] [Abstract][Full Text] [Related]
8. Effect of surfactant substitution on lung effluent phospholipids in respiratory distress syndrome: evaluation of surfactant phospholipid turnover, pool size, and the relationship to severity of respiratory failure.
Hallman M; Merritt TA; Pohjavuori M; Gluck L
Pediatr Res; 1986 Dec; 20(12):1228-35. PubMed ID: 3797115
[TBL] [Abstract][Full Text] [Related]
9. Lung surfactant phospholipids in the foetus, newborn, and in the adult; evidence of abnormality in respiratory failure.
Hallman M
Ann Chir Gynaecol Suppl; 1982; 196():19-23. PubMed ID: 6961877
[TBL] [Abstract][Full Text] [Related]
10. High concentrations of plasminogen activator inhibitor-1 in lungs of preterm infants with respiratory distress syndrome.
Cederqvist K; Sirén V; Petäjä J; Vaheri A; Haglund C; Andersson S
Pediatrics; 2006 Apr; 117(4):1226-34. PubMed ID: 16585319
[TBL] [Abstract][Full Text] [Related]
11. Endogenous surfactant metabolism in newborn infants with and without respiratory failure.
Bohlin K; Merchak A; Spence K; Patterson BW; Hamvas A
Pediatr Res; 2003 Aug; 54(2):185-91. PubMed ID: 12736380
[TBL] [Abstract][Full Text] [Related]
12. [The appearance of surface-active phospholipids of the surfactant-system of the lung during ontogenetic development of humans (author's transl)].
Winsel K; Lachmann B; Bergmann KC; Wauer R; Bauke G
Z Erkr Atmungsorgane; 1976 Mar; 144(3):220-30. PubMed ID: 989205
[TBL] [Abstract][Full Text] [Related]
13. Neonatal lung function in very immature infants with and without RDS.
Kavvadia V; Greenough A; Itakura Y; Dimitriou G
J Perinat Med; 1999; 27(5):382-7. PubMed ID: 10642959
[TBL] [Abstract][Full Text] [Related]
14. Inherited disorders of neonatal lung diseases.
Yurdakök M
Turk J Pediatr; 2004; 46(2):105-14. PubMed ID: 15214737
[TBL] [Abstract][Full Text] [Related]
15. Repeat surfactant therapy for postsurfactant slump.
Katz LA; Klein JM
J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
[TBL] [Abstract][Full Text] [Related]
16. Endogenous pulmonary surfactant metabolism is not affected by mode of ventilation in premature infants with respiratory distress syndrome.
Merchak A; Janssen DJ; Bohlin K; Patterson BW; Zimmermann LJ; Carnielli VP; Hamvas A
J Pediatr; 2002 Jun; 140(6):693-8. PubMed ID: 12072872
[TBL] [Abstract][Full Text] [Related]
17. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
[TBL] [Abstract][Full Text] [Related]
18. Maternal diabetes mellitus and changes in neonatal rat lung and alveolar surfactant phospholipids.
Koumanov K; Boyanov A; Neicheva T; Markovska T; Momchilova A
Bull Eur Physiopathol Respir; 1983; 19(5):447-51. PubMed ID: 6688958
[TBL] [Abstract][Full Text] [Related]
19. Exhaled nitric oxide and tracheal endothelin-1 in preterm infants with and without RDS.
Olsen SL; Clark PL; Thibeault DW; Norberg M; Truog WE
Pediatr Pulmonol; 2003 Nov; 36(5):421-6. PubMed ID: 14520725
[TBL] [Abstract][Full Text] [Related]
20. Use of surfactant in the prevention and treatment of neonatal respiratory distress syndrome.
Reynolds MS; Wallander KA
Clin Pharm; 1989 Aug; 8(8):559-76. PubMed ID: 2670398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
